Sophia Randolph - Dec 15, 2021 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Dec 15, 2021
Transactions value $
$33,788
Form type
4
Date filed
12/16/2021, 07:47 PM
Previous filing
Nov 23, 2021
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Options Exercise $12.7K +12.8K +7.77% $0.99* 177K Dec 15, 2021 Direct
transaction ALXO Common Stock Options Exercise $21.1K +11.1K +6.24% $1.91 188K Dec 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock Option (right to buy) Options Exercise $0 -12.8K -100% $0.00* 0 Dec 15, 2021 Common Stock 12.8K $0.99 Direct F1
transaction ALXO Stock Option (right to buy) Options Exercise $0 -11.1K -47.08% $0.00 12.4K Dec 15, 2021 Common Stock 11.1K $1.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option are fully vested and immediately exercisable.
F2 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.